JP2011006424A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011006424A5 JP2011006424A5 JP2010161643A JP2010161643A JP2011006424A5 JP 2011006424 A5 JP2011006424 A5 JP 2011006424A5 JP 2010161643 A JP2010161643 A JP 2010161643A JP 2010161643 A JP2010161643 A JP 2010161643A JP 2011006424 A5 JP2011006424 A5 JP 2011006424A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- pharmaceutical formulation
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 7
- 206010047461 Viral infection Diseases 0.000 claims 3
- 208000001756 Virus Disease Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 230000017613 viral reproduction Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000001225 therapeutic Effects 0.000 claims 2
- ARAIBEBZBOPLMB-UFGQHTETSA-N (2R,3R,4S)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 claims 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N Amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 claims 1
- 229960003805 Amantadine Drugs 0.000 claims 1
- 208000006572 Human Influenza Diseases 0.000 claims 1
- 206010022000 Influenza Diseases 0.000 claims 1
- 208000005647 Mumps Diseases 0.000 claims 1
- 208000010359 Newcastle Disease Diseases 0.000 claims 1
- 229960003752 Oseltamivir Drugs 0.000 claims 1
- VSZGPKBBMSAYNT-RRFJBIMHSA-N Oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 claims 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 claims 1
- 229960000329 Ribavirin Drugs 0.000 claims 1
- UBCHPRBFMUDMNC-UHFFFAOYSA-N Rimantadine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 claims 1
- 229960001028 Zanamivir Drugs 0.000 claims 1
- 238000005273 aeration Methods 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 229960000888 rimantadine Drugs 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
- 229960005486 vaccines Drugs 0.000 claims 1
Claims (11)
- 請求項1もしくは2に記載の化合物またはその医薬上許容される塩を、1種以上の医薬上許容される担体とともに含んでなる、医薬製剤。
- 1種以上の他の治療および/または予防成分をさらに含んでなる、請求項3に記載の医薬製剤。
- 1種以上の他の治療および/または予防成分が、ザナミビル、オセルタミビル、アマンタジン、リマンタジン、リバビリンおよび/またはインフルエンザウイルスに有効であるワクチンである、請求項4に記載の医薬製剤。
- 請求項1もしくは2に記載の化合物、または請求項3〜5のいずれか一項に記載の製剤を含んでなる、吸入器。
- 請求項1もしくは2に記載の化合物を含んでなる、ウイルス感染症の予防または治療に用いられる医薬剤。
- ウイルス感染症が、A型もしくはB型インフルエンザ感染症、パラインフルエンザ、流行性耳下腺炎またはニューカッスル病である、請求項7に記載の薬剤。
- 吸入法、通気法もしくは経鼻投与、またはその組み合わせによる気道への投与に用いられる、請求項7または8に記載の薬剤。
- ウイルス感染症の予防または治療用の医薬の製造のための、請求項1もしくは2に記載の化合物の使用。
- 請求項1もしくは2に記載の化合物を含んでなる、抗ウイルス薬。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR8795 | 2001-11-09 | ||
AUPR8795A AUPR879501A0 (en) | 2001-11-09 | 2001-11-09 | Novel chemical compounds and their use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003542184A Division JP5178989B2 (ja) | 2001-11-09 | 2002-11-08 | 二量体化合物および抗ウイルス薬としてのそれらの使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011006424A JP2011006424A (ja) | 2011-01-13 |
JP2011006424A5 true JP2011006424A5 (ja) | 2012-07-26 |
JP5179546B2 JP5179546B2 (ja) | 2013-04-10 |
Family
ID=3832614
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003542184A Expired - Fee Related JP5178989B2 (ja) | 2001-11-09 | 2002-11-08 | 二量体化合物および抗ウイルス薬としてのそれらの使用 |
JP2010161643A Expired - Fee Related JP5179546B2 (ja) | 2001-11-09 | 2010-07-16 | 二量体化合物および抗ウイルス薬としてのそれらの使用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003542184A Expired - Fee Related JP5178989B2 (ja) | 2001-11-09 | 2002-11-08 | 二量体化合物および抗ウイルス薬としてのそれらの使用 |
Country Status (14)
Country | Link |
---|---|
US (2) | US7230028B2 (ja) |
EP (1) | EP1451184B1 (ja) |
JP (2) | JP5178989B2 (ja) |
KR (1) | KR100942493B1 (ja) |
CN (1) | CN1301993C (ja) |
AT (1) | ATE398123T1 (ja) |
AU (1) | AUPR879501A0 (ja) |
CA (1) | CA2462345C (ja) |
DE (1) | DE60227101D1 (ja) |
DK (1) | DK1451184T3 (ja) |
ES (1) | ES2305301T3 (ja) |
HK (1) | HK1068344A1 (ja) |
PT (1) | PT1451184E (ja) |
WO (1) | WO2003040138A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR879501A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
EA033921B9 (ru) | 2015-11-20 | 2020-01-22 | Острэлиан Байомедикал Ко. Пти Лтд | Производные сиаловой кислоты и их применение в лечении инфекций, вызываемых вирусом гриппа |
EP3581622B1 (en) | 2017-02-10 | 2023-07-26 | Mitsubishi Chemical Corporation | Conductive composition, method for producing conductive composition, and method for producing conductor |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2106301C (en) * | 1991-03-18 | 1999-04-06 | Chi-Huey Wong | Oligosaccharide enzyme substrates and inhibitors: method and compositions |
GB9516276D0 (en) * | 1995-08-08 | 1995-10-11 | Biota Scient Management | Chemical compounds |
IL125662A0 (en) * | 1996-03-01 | 1999-04-11 | Biota Scient Management | Method of detecting influenza virus and compounds for use therein |
AUPP913999A0 (en) * | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AUPR001000A0 (en) | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AUPR879501A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AUPR879601A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
-
2001
- 2001-11-09 AU AUPR8795A patent/AUPR879501A0/en not_active Abandoned
-
2002
- 2002-11-08 AT AT02774169T patent/ATE398123T1/de not_active IP Right Cessation
- 2002-11-08 DK DK02774169T patent/DK1451184T3/da active
- 2002-11-08 WO PCT/AU2002/001528 patent/WO2003040138A1/en active IP Right Grant
- 2002-11-08 PT PT02774169T patent/PT1451184E/pt unknown
- 2002-11-08 EP EP02774169A patent/EP1451184B1/en not_active Expired - Lifetime
- 2002-11-08 ES ES02774169T patent/ES2305301T3/es not_active Expired - Lifetime
- 2002-11-08 CA CA2462345A patent/CA2462345C/en not_active Expired - Fee Related
- 2002-11-08 CN CNB028222490A patent/CN1301993C/zh not_active Expired - Fee Related
- 2002-11-08 DE DE60227101T patent/DE60227101D1/de not_active Expired - Lifetime
- 2002-11-08 KR KR1020047006445A patent/KR100942493B1/ko not_active IP Right Cessation
- 2002-11-08 US US10/494,241 patent/US7230028B2/en not_active Expired - Fee Related
- 2002-11-08 JP JP2003542184A patent/JP5178989B2/ja not_active Expired - Fee Related
-
2005
- 2005-01-20 HK HK05100550A patent/HK1068344A1/xx not_active IP Right Cessation
-
2007
- 2007-05-21 US US11/751,269 patent/US7795301B2/en not_active Expired - Fee Related
-
2010
- 2010-07-16 JP JP2010161643A patent/JP5179546B2/ja not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010285436A5 (ja) | ||
JP2010270130A5 (ja) | ||
JP2009535352A5 (ja) | ||
JP2011528713A5 (ja) | ||
MX2012007410A (es) | Compuestos antivirales novedosos. | |
SI2709613T1 (en) | Procedures for the treatment of HCV | |
JP2015534562A5 (ja) | ||
JP2013518107A5 (ja) | ||
JP2007501251A5 (ja) | ||
JP2018513188A5 (ja) | ||
JP2017515840A5 (ja) | ||
SI2932970T1 (en) | Antiviral therapy | |
JP2014530874A5 (ja) | ||
RU2007119721A (ru) | Частицы для лечения легочной инфекции | |
JP2012522001A5 (ja) | ||
JP2011225596A5 (ja) | ||
CN113304166B (zh) | 核苷类化合物在制备治疗冠状病毒感染性疾病的药物中的用途 | |
JP2014510130A5 (ja) | ||
JP2012508256A5 (ja) | ||
JP2011006424A5 (ja) | ||
JP2006507295A5 (ja) | ||
JP2011500731A5 (ja) | ||
ES2894330T3 (es) | Acido acetilsalicílico para uso en el tratamiento de la influenza de moderada a grave | |
RU2010120806A (ru) | Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид | |
RU2014136096A (ru) | Лекарственное средство для лечения и профилактики заболеваний верхних и нижних дыхательных путей различной этиологии, его применение и метод лечения на его основе |